Nuwellis (NASDAQ:NUWE) and Disaboom (OTCMKTS:MEDH) Financial Analysis

Nuwellis (NASDAQ:NUWE) and Disaboom (OTCMKTS:MEDH) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Profitability

This table compares Nuwellis and Disaboom’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nuwellis	-211.86%	-6,094.26%	-231.24%
Disaboom	15.34%	N/A	N/A

Institutional & Insider Ownership

3.1% of Nuwellis shares are held by institutional investors. 1.6% of Nuwellis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Nuwellis and Disaboom”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nuwellis	$8.27 million	0.32	-$17.52 million	($90.92)	-0.01
Disaboom	$1.76 million	0.55	$270,000.00	$0.01	0.14

Disaboom has lower revenue, but higher earnings than Nuwellis. Nuwellis is trading at a lower price-to-earnings ratio than Disaboom, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Nuwellis has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500. Comparatively, Disaboom has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Nuwellis and Disaboom, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nuwellis	1	0	1	0	2.00
Disaboom	0	0	0	0	0.00

Summary

Disaboom beats Nuwellis on 8 of the 13 factors compared between the two stocks.

About Nuwellis

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

About Disaboom

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.